ArticleCell cycle (Georgetown, Tex.)2024

ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation.

Mulin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.